fbpx
CALL US: 210-949-0122
Actively enrolling patients to keep advancing medical science - Read More »

COVID-19

COVID-19 hospitalization rates are highest among racial and ethnic minorities

What is COVID-19?

Coronavirus Disease 2019 (COVID-19) is a symptomatic disease diagnosed by testing positive for the virus along with having such symptoms as fever, chills, headache, sore throat, new smell or taste disorders, cough, shortness of breath, pneumonia or acute respiratory distress. A health professional must diagnose you with COVID-19.

Who is at risk for COVID-19?

  • Everyone
  • While everyone is at risk of getting COVID-19, some people may be more likely to get COVID-19 or experience severe illness
  • Severe illness and death rates tend to be higher for racial and ethnic minorities

What type of research is being conducted?

  • Currently, CTT is conducting COVID-19 Vaccine Studies
  • COVID-19 Vaccine Studies do NOT involve live virus and patients will NOT be exposed to the virus as part of the study

Risk Factors for COVID-19

Not Social Distancing

Living in Hot Spot

Working or Living in Close Quarters

Ethnic/Racial Minorities

CTT & COVID-19 in the News

CTT COVID-19 Vaccine Study

Dr. Douglas Denham, chief medical director of CTT, talks to KENS5 about a new COVID-19 Vaccine Study being conducted by CTT.

KENS5»

CTT Selected for Vaccine Study

CTT Chief Medical Director, Dr. Douglas Denham, talks to Camilla Rambaldi about an upcoming COVID-19 Vaccine Study at CTT.

FOX San Antonio»

CTT to Begin Moderna Study

CTT Chief Medical Director, Dr. Douglas Denham, talks to KSAT reporter Deven Clarke about participating in the Moderna Phase 3 trial, as the only site in San Antonio .

KSAT»

CTT Seeking Minorities for COVID-19 Vaccine Trial

CTT Investigator, Dr. Ayoade Avworo, speaks to Jeremy Baker of KENS5 about the importance of minority participation in clinical trials.

KENS5»

CTT Selected for Phase 3 Vaccine Trial

CTT Chief Medical Director, Dr. Douglas Denham, talks to Jeremy Baker about CTT’s involvement in the Moderna upcoming COVID-19 Vaccine Study at CTT.

KENS5»

CTT Starting Moderna Trial

Dr. Douglas Denham, chief medical director of CTT, talks to Fox San Antonio about a new COVID-19 Vaccine Study being conducted by CTT.

FoxSanAntonio»

CTT Seeks At-Risk Participants for COVID-19 Vaccine Trial

CTT Chief Medical Director, Dr. Douglas Denham, talks to Rivard Report about an upcoming COVID-19 Vaccine Study at CTT.

Rivard Report»

CTT Looking for Volunteers

CTT Recruitment Team Lead, Edna Arce, talks to Telemundo about the Moderna Phase 3 trial.

Telemundo»

CTT Begins Pfizer COVID-19 Vaccine Trials

CTT President/CEO Kay Scroggins, RN talks to KSAT’s Deven Clarke about CTT conducting the Pfizer COVID-19 vaccine trial.

KSAT»

First Moderna Patient in S. Texas at CTT

San Antoinio Express News was on hand to document the historic contribution of Mary Dixson as the first patient to receive an injection in the area from Dr. Ayo Avworo at CTT.

San Antonio Express News»

Participate in COVID-19 Studies

Participate in a COVID-19 clinical trial in San Antonio, TX to help us find a solution to the COVID-19 pandemic through medical science. There’s no cost to you or insurance required. Compensation is available. It’s easy, just browse currently enrolling studies and apply online to see if you qualify.

Participate in Liver Disease (Fatty Liver) Studies CTT Clinical Trials of Texas, Inc San Antonio SAResearch.com research studies medical

Thank you for your interest in participating in research at Clinical Trials of Texas, Inc. in San Antonio, TX. If you have any questions, we would love to hear from you! Please call us or message us, or for more information on clinical trials:

WHAT ARE CLINICAL RESEARCH STUDIES?
REASONS TO PARTICIPATE
ARE CLINICAL TRIALS SAFE?